Shelter Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 28 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 935.24%
- Profit Growth 2289.84%
- Ebitda 2289.84%
- Net Worth
- Total Assets 1398.15%
About Shelter Pharmacy
Shelter Pharmacy Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 1996 and has a history of 28 years and two months. Its registered office is in Sabarkantha, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nusrat Sabugar, Shakil Sabugar, Parvezbanu Idariya, and Two other members serve as directors at the Company.
Company Details
-
Location
Sabarkantha, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1996PTC031166
-
Company No.
031166
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Nov 1996
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Shelter Pharmacy?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nusrat Sabugar
|
Director | 15-Jun-2005 | Current |
|
Shakil Sabugar
|
Director | 15-Jun-2005 | Current |
|
Parvezbanu Idariya
|
Director | 15-Jun-2005 | Current |
|
Zubedabibi Sabugar
|
Director | 15-Jun-2005 | Current |
|
Mustaqim Sabugar
|
Director | 21-Nov-1996 | Current |
Financial Performance of Shelter Pharmacy.
Shelter Pharmacy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 935.24% increase. The company also saw a substantial improvement in profitability, with a 2289.84% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shelter Pharmacy?
In 2020, Shelter Pharmacy had a promoter holding of 99.80% and a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shelter Pharma LimitedShakil Sabugar, Parvezbanu Idariya and 1 more are mutual person
-
Poly9 Software Sales Private LimitedMustaqim Sabugar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shelter Pharmacy?
Unlock and access historical data on people associated with Shelter Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shelter Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shelter Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
